Avise Financial Cooperative’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Buy
441
+52
+13% +$53.1K 0.37% 58
2026
Q1
$357K Buy
389
+1
+0.3% +$1.01K 0.3% 67
2025
Q4
$416K Buy
+388
New +$371K 0.38% 50

Other funds holding LLY

Avise Financial Cooperative's LLY Position: Q2 2026 in Review

Avise Financial Cooperative increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $53.1K and bringing the position to 441 shares worth $528K. The position accounts for 0.37% of the portfolio, ranked #58.

Avise Financial Cooperative first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Avise Financial Cooperative held 441 shares of Eli Lilly worth $528K as of Q2 2026.
  • Avise Financial Cooperative bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.37% of Avise Financial Cooperative's portfolio in Q2 2026, its #58 holding.
  • Avise Financial Cooperative first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Avise Financial Cooperative's 13F filing for Q2 2026, filed 6 Aug 2026.